HIV TREATMENT
2020
Action 27. Mobilize their networks and work with communities to help build treatment literacy, generate demand, and expand access to ARVs among children.
Action 34. Increase efforts to share information on the roll-out of new paediatric formulations, including lessons learned.
Paediatric HIV & TB : Rome Action Plan
IMPAACT commits to:
​
222. Determine dosing and safety of DTG dispersible tablets in newborns by third quarter 2024
​
223. Determine safety, dosing, and acceptability of long-acting injectable ART with cabotegravir and rilpivirine in adolescents by second quarter of 2024 and children over age 2 years by second quarter of 2024.
​
224. IMPAACT to collaborate with GAP-f partners and appropriate research networks to implement a platform trial to assess innovative options to deliver postnatal prophylaxis
-
​
​